A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low-grade glioma (LGG). (Q46088442)
Jump to navigation
Jump to search
scientific article published on 20 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low-grade glioma (LGG). |
scientific article published on 20 March 2012 |
Statements
1 reference
A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low-grade glioma (LGG). (English)
1 reference
Michal Yalon
1 reference
Brian Rood
1 reference
Tobey J MacDonald
1 reference
Geoff McCowage
1 reference
Rochelle Kane
1 reference
Shlomi Constantini
1 reference
Roger J Packer
1 reference
20 March 2012
1 reference
1 reference
60
1 reference
1
1 reference
71-76
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference